Skip to content
Select language:
Select Language
Arabic
Bengali
Chinese (Simplified)
Chinese (Traditional)
Croatian
Dutch
English
Filipino
French
German
Greek
Hindi
Indonesian
Italian
Japanese
Khmer
Korean
Macedonian
Polish
Portuguese
Punjabi
Russian
Samoan
Spanish
Tamil
Thai
Turkish
Urdu
Vietnamese
1800 620 420
Blood cancer information
How we can help
Get involved
Donate
Donate
Menu
Search
Home
Blood cancer information
COVID-19 and blood cancer
Blood cancer signs and symptoms
Types of blood cancer
Understanding your blood
What is blood?
The bone marrow and blood formation
The lymphatic system
Blood tests
Blood cancer statistics
Leukaemia
Acute myeloid leukemia (AML)
AML diagnosis
Acute myeloid leukaemia treatment
Side effects of AML treatment
Acute lymphoblastic leukaemia (ALL)
ALL diagnosis
ALL treatment
ALL treatment side-effects
Promyelocytic leukaemia (APML)
APML diagnosis
APML treatment
APML treatment side-effects
Chronic myeloid leukaemia (CML)
CML diagnosis
CML treatment
CML treatment side-effects
Chronic lymphocytic leukaemia (CLL)
CLL diagnosis
CLL treatment
CLL treatment side-effects
Richter’s Syndrome
Hairy cell leukaemia
Hairy cell leukaemia diagnosis
Hairy cell leukaemia treatment
Hairy cell leukaemia treatment side-effects
Biphenotypic leukaemia (BAL)
Lymphoma
Non-Hodgkin lymphoma
Non-Hodgkin lymphoma diagnosis
Non-Hodgkin lymphoma treatment
Non-Hodgkin lymphoma treatment side-effects
Adult T-cell lymphoma
Anaplastic large cell lymphoma
Burkitt’s lymphoma
Diffuse large B-cell lymphoma
Double hit lymphoma
Follicular lymphoma
Lymphoblastic lymphoma
Mantle cell lymphoma
Mucosa-associated lymphoid tissue lymphoma
Nodal marginal zone lymphoma
Peripheral T-cell lymphoma
Primary central nervous system lymphoma
Skin lymphomas
Small lymphocytic lymphoma
Hodgkin lymphoma
Hodgkin lymphoma diagnosis
Hodgkin lymphoma treatment
Hodgkin lymphoma treatment side-effects
Myeloma
Myeloma diagnosis
Myeloma treatment
Myeloma treatment side-effects
Monoclonal gammopathy of unknown significance (MGUS)
Myelodysplastic syndromes (MDS)
MDS diagnosis
MDS treatment
MDS treatment side-effects
Deletion 5q
Myelodysplastic Syndrome – RAEB
Refractory Anaemia with Ring Sideroblasts (MDS – RARS)
Refractory Cytopaenia with Unilineage Dysplasia (MDS – RCUD)
Chronic Myelomonocytic Leukaemia (CMML)
Myeloproliferative neoplasms (MPN)
MPN diagnosis
MPN treatment
MPN treatment side effects
Polycythaemia (rubra) vera
Essential thrombocythaemia (ET)
Myelofibrosis
Amyloidosis
Amyloidosis diagnosis
Amyloidosis treatment
Amyloidosis treatment side-effects
AL amyloidosis
Waldenstrom’s macroglobulinaemia (WM)
Waldenstrom’s macroglobulinaemia diagnosis
Waldenstrom’s macroglobulinaemia treatment
Waldenstrom’s macroglobulinaemia treatment side-effects
Aplastic anaemia
Aplastic anaemia diagnosis
Aplastic anaemia treatment
Aplastic anaemia treatment side-effects
Childhood blood cancers
Childhood lymphoma
Childhood lymphoma diagnosis
Childhood lymphoma treatment
Childhood lymphoma treatment side-effects
Childhood ALL
Childhood ALL diagnosis
Childhood ALL treatment
Childhood ALL treatment side-effects
Childhood acute myeloid leukaemia (AML)
Childhood AML diagnosis
Childhood AML treatment
Childhood AML treatment side-effects
Juvenile myelomonocytic leukaemia (JMML)
Childhood JMML diagnosis
Childhood JMML treatment
Childhood JMML treatment side-effects
Childhood MDS and MPN
Childhood MDS and MPN diagnosis
Childhood MDS and MPN treatment
Childhood MDS and MPN treatment side-effects
Children and blood cancer
The blood cancer journey
Newly diagnosed
What happens next?
Telling people
Pregnancy and blood cancer
Your healthcare rights
In active treatment
Treatment options for blood cancer
Chemotherapy
Stem cell transplants
Autologous stem cell transplants
Allogeneic stem cell transplants
Graft versus host disease (GVHD)
Sources of stem cell transplants
Haploidentical stem cell transplant
Targeted and biological therapies
Clinical trials
Guides to Best Cancer Care
Wellbeing during treatment
Viruses and blood cancer
Diet and nutrition during treatment
Relationships and intimacy
Other side effects
Osteonecrosis of the jaw
Iron overload/chelation
Peripheral neuropathy
Not in active treatment
Life after treatment
Living well with blood cancer
Emotional health
Mental health
Relationships and sex
Practical matters
Working and studying
Money and finances
Travel and holidays
Useful contacts
Food safety and nutrition
Grief and loss
Grief
Palliative care
Getting my affairs in order
Advance care planning
Legal matters
Finances
Superannuation
Seeking help
Useful contacts
Carers and friends
Online carers course
Supporting people with a blood cancer
Being a carer
Adjusting to being a carer
Day to day caring
Carers and the health system
Financial and legal support for carers
Carer resources
For healthcare professionals
Refer a patient for support services
Optimal Care Pathways for blood cancer
Real stories
How we can help
Submit a Request for Support Services
Accommodation services
About our accommodation services
Policies and reimbursements
Clem Jones – Sunland Village (Brisbane)
ESA Village (Brisbane)
Herston Village (Brisbane)
Village Green Apartments (Brisbane)
Freemasons Village (Townsville)
Sydney and Newcastle
Building of Hope (Melbourne)
Bridgestone Australia Village (Adelaide)
John James Village (Canberra)
Stirling Cross Apartments (Perth)
Transport services
Information and education services
Talking Blood Cancer Podcast
Download our information booklets
Disease e-newsletters
Disease newsletter archive
Optimal Care Pathways for blood cancer treatment
Glossary of common terms
Links to other resources
Emotional support services
Health and wellbeing support services
Access to Exercise
Grief and bereavement support services
Online education and support
Assessment and referral services
Research
National Research Program
PhD scholarship recipients
Cancer Australia PdCCRS recipients
Strategic Ecosystem Research Partnership Grants
Multiomic analysis in Waldenstrom’s Macroglobulinemia
Developing state-of-the art molecular genomic testing in cancer diagnosis and monitoring
Establishing a new prognostic score for follicular lymphoma
Deep profiling of ALL and myeloma for targeted therapies
Understanding the process of progression from MDS to acute leukaemia
Characterisation of a novel DCAF factor as a blood cancer therapy
Precision Medicine in ALL
The Centre for Blood Transplant and Cell Therapy
The role of the bone marrow microenvironment in the myeloma plasma cell dormancy and reactivation
LLS Translational Research Program Grant recipients
Clinical trials
Clinical trials: FAQs
Blood Cancer Genomics Trial
The Trials Enabling Program
Trials Enabling Program: FAQs
Clinical trial for Advanced Stage Hodgkin Lymphoma
Clinical trial for high tumour burden follicular lymphoma
Clinical trial for newly diagnosed AML or MDS with IDH1 or IDH2 mutation
Clinical trial for newly diagnosed AML or MDS with FLT3 mutation
Past research
Current funding opportunities
PhD Scholarships Program
PdCCRS Cancer Australia Grants
Research in action
Advocacy and policy
Optimal Care Pathways
Position statements
National Strategic Action Plan for Blood Cancer
Set the Standard for Blood Cancer
State of the Nation report and My Life Counts
National Blood Cancer Taskforce
Get involved
Make a donation
Blood Cancer Month
Fundraise
Create your own fundraiser
Join an event
World’s Greatest Shave
Light the Night
Dry July
Team Beat Blood Cancer
Join our Consumer Engagement Program
Volunteer
Business partnerships
Partnerships with the Leukaemia Foundation
Our partners
Corporate volunteering
In Kind Sponsorship
Workplace Giving
Join a community group
Events
Previous Webinars
Other ways to get involved
Donate your blood or bone marrow
Share your blood cancer story
Join our Branch network
Advocacy and policy
New Normal Same Cancer
Make a donation
Make a donation
Donate to our Appeal
Become a regular giver
Donate in Memory
Leave a Gift in Will
Will planning checklist
Gift in Will stories
Gift in Will FAQs
Workplace Giving
Focused Philanthropy
About us
Who we are
Board and CEO
Careers
Current vacancies
Annual reports and statements
Position statements
Reconciliation Action Plan
News
Media releases
Media hub
Guidelines for reporting on blood cancer
Blood cancer facts and stats
Meet our Executives and experts
Images and videos for download
Media contacts
Stories
Lifeblood
Disease newsletters
Subscribe to our news
Contact us
New South Wales & the Australian Capital Territory
Victoria
Queensland
Western Australia
South Australia & Northern Territory
Tasmania
Close menu
Search
Thank you
We’ve received your details and you’ve been added to our subscriber list.